Review Article
Effect of Gastrointestinal Surgical Manipulation on Metabolic Syndrome: A Focus on Metabolic Surgery
Table 1
Bariatric surgery outcomes (weight loss and comorbidities resolution rate) (5–19, 39–42). Long term: followup > 3 years.
| | | LAGB | RYGBP | BPD-DS | LSG | | | 1 year | Long term | 1 year | Long term | 1 year | Long term | 1 year | Long term |
| | % EWL | 48 | 42.1 | 75 | 69 | 55 | 80 | 57.7% | 66% | | Hypertension | 55% | 56% | 46% | 81% | 52.9% | 40% | 62.5% | 85.7% | | T2DM | 58% | 50% | 72% | 82% | 74% | 90% | 76.9% | 83% | | Dyslipidemia | 42% | 40% | 65% | 40% | 64.9% | 44% | 34% | 80% | | OSAS | 45% | 46% | 75% | 60% | 44% | 52% | 56.2% | 66% |
|
|
